[Survivin expression in ovarian carcinoma].
Rutie Yin, Zhilan Peng, Kaixuan Yang, De-ying Kang
Abstract
Rutie Yin, Zhilan Peng, Kaixuan Yang, De-ying Kang
Abstract
OBJECTIVE: To explore the possible relationship between expression of survivin and molecular mechanisms in patients with ovarian carcinoma (OC). METHODS: Survivin expressions in normal ovaries (n= 10), ovarian bordline tumors (n = 21), and ovarian serous cystadenomas (n = 38) were investigated by means of immunohistochemistry. RESULTS: No survivin protein was expressed in normal ovaries. Survivin protein was found in cytoplasm and/or in nucleus of tumor cell. Survivin expression was revealed in 42.9% (9/21) of ovarian bordline tumors; no significant correlation was observed between survivin expression and pathologic types or CA125 values (P > 0.05). Survivin protein was found in 76.3% (29/38) of ovarian serous cystadenomas, displaying a significantly higher expression than that in bordline tumors (P < 0.05). Survivin expression was positively correlated with tumor stage, histological grade and lymphonode metastasis (P < 0.05), whereas it was not significantly correlated with CA125 values, volume of ascites, and presence/absence of tumor cells in ascites (P > 0.05). CONCLUSION: High expression of Survivin protein may be related with the differentiation and metastasis of epithelial ovarian carcinoma.
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To explore the possible relationship between expression of survivin and molecular mechanisms in patients with ovarian carcinoma (OC). METHODS: Survivin expressions in normal ovaries (n= 10), ovarian bordline tumors (n = 21), and ovarian serous cystadenomas (n = 38) were investigated by means of immunohistochemistry. RESULTS: No survivin protein was expressed in normal ovaries. Survivin protein was found in cytoplasm and/or in nucleus of tumor cell. Survivin expression was revealed in 42.9% (9/21) of ovarian bordline tumors; no significant correlation was observed between survivin expression and pathologic types or CA125 values (P > 0.05). Survivin protein was found in 76.3% (29/38) of ovarian serous cystadenomas, displaying a significantly higher expression than that in bordline tumors (P < 0.05). Survivin expression was positively correlated with tumor stage, histological grade and lymphonode metastasis (P < 0.05), whereas it was not significantly correlated with CA125 values, volume of ascites, and presence/absence of tumor cells in ascites (P > 0.05). CONCLUSION: High expression of Survivin protein may be related with the differentiation and metastasis of epithelial ovarian carcinoma.
Key concepts: Survivin, Immunohistochemistry, Ovarian carcinoma, Metastasis, Serous Cystadenoma, Serous fluid, Ascites, Ovarian tumor